Literature DB >> 22723340

Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.

Shu-Yun Zhang1, Sailesh Surapureddi, Sherry Coulter, Stephen S Ferguson, Joyce A Goldstein.   

Abstract

The CYP2C genes are extensively regulated at the transcriptional stage. The present study shows for the first time that CYP2Cs are also regulated post-transcriptionally by microRNAs (miRNAs). By using online search engines, we found potential miRNA response elements (MREs) in the 3'-untranslated region (3'-UTR) of the CYP2C mRNAs. Among these were a MRE for the miRNAs miR-103 and miR-107 in the 3'-UTR of human CYP2C8. CYP2C8 protein levels (measured through immunoblot analyses) did not correlate with CYP2C8 mRNA levels (measured through quantitative polymerase chain reaction analyses) in human liver samples. The translation efficiency (protein/mRNA ratio) for CYP2C8 was inversely correlated with the expression of miR-103 and miR-107. When three copies of the putative MRE from CYP2C8 were inserted downstream from a luciferase expression reporter, transfection with precursors for miR-103 or miR-107 decreased luciferase activity in primary hepatocytes, whereas transfection with antisense oligonucleotides (AsOs) for miR-103/miR-107 increased luciferase activity. As expected, there was no effect of the precursors or AsOs when three copies of the putative MRE were inserted in the reverse orientation. When precursors for miR-103/miR-107 were transfected into primary human hepatocytes, CYP2C8 protein levels were decreased, whereas AsOs increased CYP2C8 protein levels. Neither precursors nor AsOs affected CYP2C8 mRNA levels, which indicated that the effect was post-transcriptional. Putative MRE motifs were also found in the 3'-UTRs of CYP2C9 and CYP2C19, which suggested that the same miRNAs could regulate translation of other members of the CYP2C family, although to a lesser degree than CYP2C8. These results clearly show that CYP2Cs are regulated post-transcriptionally by miR-103 and miR-107.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723340      PMCID: PMC3422698          DOI: 10.1124/mol.112.078386

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  60 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors.

Authors:  Miki Nakajima; Tsuyoshi Yokoi
Journal:  Pharmacol Ther       Date:  2011-04-30       Impact factor: 12.310

Review 3.  MicroRNAs as new therapeutic targets and tools in cancer.

Authors:  Paolo Gandellini; Valentina Profumo; Marco Folini; Nadia Zaffaroni
Journal:  Expert Opin Ther Targets       Date:  2011-01-05       Impact factor: 6.902

4.  MicroRNAs 103 and 107 regulate insulin sensitivity.

Authors:  Mirko Trajkovski; Jean Hausser; Jürgen Soutschek; Bal Bhat; Akinc Akin; Mihaela Zavolan; Markus H Heim; Markus Stoffel
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes.

Authors:  Sailesh Surapureddi; Ritu Rana; Joyce A Goldstein
Journal:  Pharmacol Res       Date:  2011-02-01       Impact factor: 7.658

6.  Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.

Authors:  Matthew L Edin; Zhongjing Wang; J Alyce Bradbury; Joan P Graves; Fred B Lih; Laura M DeGraff; Julie F Foley; Robert Torphy; Oline K Ronnekleiv; Kenneth B Tomer; Craig R Lee; Darryl C Zeldin
Journal:  FASEB J       Date:  2011-06-22       Impact factor: 5.191

7.  Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

Authors:  A Rahman; K R Korzekwa; J Grogan; F J Gonzalez; J W Harris
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

8.  Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1.

Authors:  K Inoue; J Inazawa; Y Suzuki; T Shimada; H Yamazaki; F P Guengerich; T Abe
Journal:  Jpn J Hum Genet       Date:  1994-09

9.  Post-transcriptional regulation of mouse renal cytochrome P450 2E1 by testosterone.

Authors:  J Pan; J Y Hong; C S Yang
Journal:  Arch Biochem Biophys       Date:  1992-11-15       Impact factor: 4.013

Review 10.  Biochemistry and molecular biology of the human CYP2C subfamily.

Authors:  J A Goldstein; S M de Morais
Journal:  Pharmacogenetics       Date:  1994-12
View more
  28 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223.

Authors:  Eric A Benson; Todd C Skaar
Journal:  Drug Metab Dispos       Date:  2013-07-25       Impact factor: 3.922

3.  MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells.

Authors:  Dianke Yu; Bridgett Green; William H Tolleson; Yaqiong Jin; Nan Mei; Yongli Guo; Helen Deng; Igor Pogribny; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2015-08-19       Impact factor: 5.858

4.  CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver.

Authors:  Ngome L Makia; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2015-10-14       Impact factor: 4.436

5.  Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil.

Authors:  Cunzhong Shi; Luo Min; Julin Yang; Manyun Dai; Danjun Song; Huiying Hua; Gangming Xu; Frank J Gonzalez; Aiming Liu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-05-10       Impact factor: 4.080

6.  Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.

Authors:  Dongying Li; William H Tolleson; Dianke Yu; Si Chen; Lei Guo; Wenming Xiao; Weida Tong; Baitang Ning
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2019-07-15       Impact factor: 3.781

7.  MicroRNAs and Heat Shock Proteins in Breast Cancer Biology.

Authors:  Mehmet Taha Yildiz; Lütfi Tutar; Nazlı Irmak Giritlioğlu; Banu Bayram; Yusuf Tutar
Journal:  Methods Mol Biol       Date:  2022

8.  Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression.

Authors:  Zhe Shi; Wenjun Yang; Joyce A Goldstein; Shu-Yun Zhang
Journal:  Biochem Pharmacol       Date:  2014-06-21       Impact factor: 5.858

9.  Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107.

Authors:  Zhigang Lu; Jin Xu; Mingming Xu; Gavril W Pasternak; Ying-Xian Pan
Journal:  Mol Pharmacol       Date:  2013-12-03       Impact factor: 4.436

10.  Regulation of human CYP2C9 expression by electrophilic stress involves activator protein 1 activation and DNA looping.

Authors:  Ngome L Makia; Sailesh Surapureddi; Katalin Monostory; Russell A Prough; Joyce A Goldstein
Journal:  Mol Pharmacol       Date:  2014-05-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.